Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse

European Journal of Pharmacology

Volumn 366, Issue 2-3, 1999, Pages 127-135

  Huang, Wei ^a   Chen, Yun ^a   Shohami, Esther ^a   Weinstock, Marta ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Brain oedema; Cholinergic mediation; Monoamine oxidase B inhibition; Motor function; Neuroprotection; Spatial memory

Indexed keywords

BRAIN MONOAMINE; MONOAMINE OXIDASE INHIBITOR; RASAGILINE; SCOPOLAMINE; TPV 1021; UNCLASSIFIED DRUG;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN INJURY; CONTROLLED STUDY; DRUG EFFICACY; HEAD INJURY; HEMISPHERE; MALE; MOTOR PERFORMANCE; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SPATIAL MEMORY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN EDEMA; HEAD INJURIES, CLOSED; INDANS; MALE; MAZE LEARNING; MEMORY DISORDERS; MEMORY, SHORT-TERM; MICE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR DISORDERS; PSYCHOMOTOR PERFORMANCE;

EID: 0032999575     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00929-7     Document Type: Article

References (34)

1. Ansari K.S., Yu P.H., Kruck T.P.A., Tatton W.G. Rescue of axotomized immature rat motorneurons by R-(-)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition. J. Neurosci. 13:1993;4042-4053.
2. Biegon A., Bar Joseph A. Development of HU-211 as a neuroprotectant for ischemic brain damage. Neurol. Res. 17:1995;275-280.
3. Capruso D.X., Levin H.S. Cognitive impairment following closed head injury. Neurol. Clin. 10:1992;879-893.
4. Chen Y., Constantini S., Trembovler V., Weinstock M., Shohami E. An experimental model of closed head injury in mice: pathophysiology, histopathology and cognitive deficits. J. Neurotrauma. 13:1996;557-569.
5. Chen Y., Shohami E., Constantini S., Weinstock M. Rivastigmine, a brain-selective acetylcholinesterase inhibitor, ameliorates cognitive and motor deficits induced by closed head injury in the mouse. J. Neurotrauma. 15:1998;231-237.
6. Finberg, J.P.M., Lamensdorf, I., Weinstock, M., Schwartz, M., Youdim, M.B.H., 1998a. The pharmacology of rasagiline (N-propargyl-1R-aminoindan). In: Stern, G. (Ed.), Parkinson's Disease. Adv. Neurol. Lippincott-Raven, Philadelphia, in press.
7. Finberg J.P.M., Takeshima T., Johnston J.M., Commissiong J.W. Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase-B inhibitor. NeuroReport. 9:1998;703-707.
8. Gorman L.K., Fu D.A., Hovda D.A., Murray M., Traystman R.J. Effects of traumatic brain injury on the cholinergic system in the rat. J. Neurotrauma. 13:1996;457-463.
9. Hamm R.J., Temple M.D., Pike B.R., O'Dell D.M., Buck D.L., Lyeth B.G. Working memory deficits following traumatic brain injury in the rat. J. Neurotrauma. 13:1996;317-323.
10. Heinonen E.H., Anttila M.I., Lammintausta R.A. Pharmacokinetic aspects of L-deprenyl (selegiline) and its metabolites. Clin. Pharmacol. Ther. 56:1994;742-749.
11. Imperato A., Obinu M.C., Mascia M.S., Casu M.A., Zchi A., Cabib S., Puglisi-Allegra S. Strain-dependent effects of dopamine agonists on acetylcholine release in the hippocampus: an in vivo study in mice. Neuroscience. 70:1996;653-660.
12. Klatzo I. Neuropathological aspects of brain edema. J. Neuropathol. Exp. Neurol. 26:1967;1-14.
13. Knollema S., Aukema W., Hom H., Korf J., Horst G.J.T. L-Deprenyl reduces brain damage in rats exposed to transient hypoxia-ischemia. Stroke. 26:1995;1883-1887.
14. 1 pyramidal cells in the hippocampus. Brain Res. 757:1997;260-267.
15. Leonard J.R., Maris D.O.A., Grady M.S. Fluid percussion injury causes loss of forebrain choline acetyl transferase and nerve growth factor receptor immunoreactive cells in the rat. J. Neurotrauma. 4:1994;379-392.
16. Lobato R., Sarabia R., Cordobes F., Rivas J., Adrados A., Cargrere A., Gomez P., Madera A., Lamas E. Post-traumatic cerebral hemispheric swelling. J. Neurosurg. 68:1988;417-423.
17. Martinez-Murillo R., Semenenko F., Cuello A.C. The origin of tyrosine hydroxylase-immunoreactive fibers in the regions of the nucleus basalis magnocellularis of the rat. Brain Res. 451:1988;227-236.
18. Nilsson O.G., Gampieri L., Björklund A. Acetylcholine release in the hippocampus: regulation by monoaminergic afferents as assessed by in vivo micro dialysis. Brain Res. 584:1992;132-140.
19. O'Carrol A., Fowler C.K., Phillips J.P., Tobbia I., Tipton K.F. The deamination of dopamine by human brain monoamine oxidase. Naunyn-Schmiedeberg's Arch. Pharmacol. 322:1983;198-202.
20. Oh C., Murray B., Bhattacharya N., Holland D., Tatton W.G. (-)-Deprenyl alters the survival of adult murine facial motorneurons after axotomy: increases in vulnerable C57BL strain but decreases in motor neurone degeneration mutants. J. Neurosci. Res. 38:1994;64-74.
21. Otsuka S., Kobayashi Y. A radioisotope assay for monoamine oxidase determination in human plasma. Biochem. Pharmacol. 13:1964;995-1006.
22. Paterson I.A., Barber A.J., Gelowitz D.L., Voll C. (-)-Deprenyl reduces delayed neuronal death of hippocampal pyramidal cells. Neurosci. Biobehav. Rev. 21:1997;181-186.
23. 2 receptor antagonist, improves cognitive performance following traumatic brain injury in rats. Brain Res. 686:1995;37-43.
24. Semkova I., Wolz P., Shilling M., Kriegel J. Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage. Eur. J. Pharmacol. 315:1996;19-30.
25. Shohami E., Novikov M., Bass R. Long-term effect of HU-211, a novel, non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat. Brain Res. 674:1995;55-62.
26. Shohami E., Beit-Yannai E., Horowitz M., Kohen R. Oxidative stress in closed head injury: brain antioxidant capacity as an indicator of functional outcome. J. Cereb. Blood Flow Metab. 17:1997;1007-1019.
27. Smiley, J.F., Mesulam, M.M., 1996. The anatomy of monoaminergic-cholinergic interactions in the primate basal forebrain. In: Becker, R., Giacobini, E. (Eds.), Alzheimer Disease: From Molecular Biology to Therapy. Birkhauser, Boston, pp. 159-164.
28. Smith D.H., Okiyama K., Thomas M.J., Claussen B., McIntosh T.K. Evaluation of memory dysfunction following experimental brain injury using the Morris water maze. J. Neurotrauma. 8:1991;259-269.
29. Smith S.L., Andrus P.K., Zhang J.R., Hall E.D. Direct measurement of hydroxyl radicals, lipid peroxidation, and blood-brain barrier disruption following unilateral cortical impact head injury in the rat. J. Neurotrauma. 11:1994;393-404.
30. Speizer Z., Katzir O., Rehavi M., Zabarski T., Cohen S. Sparing by rasagiline (TVP1012) of cholinergic functions and behavior in the postnatal anoxia rat. Pharmacol. Biochem. Behav. 60:1998;1-7.
31. Sterling J., Veinberg A., Lerner D., Goldenberg W., Levy R., Youdim M., Finberg J. (R)(+)-N-Propargyl-1-aminoindan (rasagiline) and derivatives: highly selective and potent inhibitors of monoamine oxidase-B. J. Neural Transm. 52:1998;301-305.
32. Uyama O., Okamara N., Yumase M., Narita M., Kawabata K., Sugita M. Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evan's blue fluorescence. J. Cereb. Blood Flow Metab. 8:1988;282-284.
33. Yamaguchi T., Ozawa Y., Suzuki M., Yamamoto M., Nakamura T., Yamaura A. Indeloxazine hydrochloride improves impairment of passive avoidance performance after fluid percussion brain injury in rats. Neuropharmacology. 35:1996;329-336.
34. Zauner A., Bullock R. The role of excitatory amino acids in severe brain trauma: opportunities for therapy: a review. J. Neurotrauma. 12:1995;547-554.